These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 1574992
1. Treatment of Wilson's disease: penicillamine or triene? Kiechl SG, Willeit J, Aichner F, Felber S. Acta Neurol Scand; 1992 Feb; 85(2):154-7. PubMed ID: 1574992 [No Abstract] [Full Text] [Related]
2. Treatment of Wilson's disease: what are the relative roles of penicillamine, trientine, and zinc supplementation? Schilsky ML. Curr Gastroenterol Rep; 2001 Feb; 3(1):54-9. PubMed ID: 11177695 [Abstract] [Full Text] [Related]
3. Treatment of Wilson's disease. Deiss A. Ann Intern Med; 1983 Sep; 99(3):398-400. PubMed ID: 6614689 [No Abstract] [Full Text] [Related]
4. Mode of action of triethylenetetramine dihydrochloride on copper metabolism in Wilson's disease. Siegemund R, Lössner J, Günther K, Kühn HJ, Bachmann H. Acta Neurol Scand; 1991 Jun; 83(6):364-6. PubMed ID: 1887758 [Abstract] [Full Text] [Related]
5. Practical recommendations and new therapies for Wilson's disease. Brewer GJ. Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757 [Abstract] [Full Text] [Related]
6. Wilson's disease: an update, with emphasis on new approaches to treatment. Brewer GJ, Yuzbasiyan-Gurkan V. Dig Dis; 1989 Aug; 7(4):178-93. PubMed ID: 2663256 [No Abstract] [Full Text] [Related]
7. Treatment of Wilson's disease with triethylene tetramine hydrochloride (Trientine). Dubois RS, Rodgerson DO, Hambidge KM. J Pediatr Gastroenterol Nutr; 1990 Jan; 10(1):77-81. PubMed ID: 2324883 [Abstract] [Full Text] [Related]
8. The mechanisms of penicillamine, trientine, and zinc in the treatment of Wilson's disease. Yarze JC. Am J Gastroenterol; 1995 Jun; 90(6):1026. PubMed ID: 7771405 [No Abstract] [Full Text] [Related]
9. Wilson's disease treatment by triethylene tetramine dihydrochloride (trientine, 2HCl): long-term observations. Morita J, Yoshino M, Watari H, Yoshida I, Motohiro T, Yamashita F, Okano Y, Hashimoto T. Dev Pharmacol Ther; 1992 Jun; 19(1):6-9. PubMed ID: 1307347 [Abstract] [Full Text] [Related]
10. Wilson's disease. Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML. Lancet; 2007 Feb 03; 369(9559):397-408. PubMed ID: 17276780 [Abstract] [Full Text] [Related]
11. Current Drug Managements of Wilson's Disease: From West to East. Li WJ, Chen C, You ZF, Yang RM, Wang XP. Curr Neuropharmacol; 2016 Feb 03; 14(4):322-5. PubMed ID: 26639459 [Abstract] [Full Text] [Related]
12. Clinical considerations for an effective medical therapy in Wilson's disease. Weiss KH, Stremmel W. Ann N Y Acad Sci; 2014 May 03; 1315():81-5. PubMed ID: 24754532 [Abstract] [Full Text] [Related]
13. Recognition, diagnosis, and management of Wilson's disease. Brewer GJ. Proc Soc Exp Biol Med; 2000 Jan 03; 223(1):39-46. PubMed ID: 10632959 [Abstract] [Full Text] [Related]
14. The treatment of Wilson's disease, a rare genetic disorder of copper metabolism. Purchase R. Sci Prog; 2013 Jan 03; 96(Pt 1):19-32. PubMed ID: 23738435 [Abstract] [Full Text] [Related]
17. Treatment of Wilson's disease: in D-penicillamine we trust--what about zinc? Lipsky MA, Gollan JL. Hepatology; 1987 Sep 03; 7(3):593-5. PubMed ID: 3570170 [No Abstract] [Full Text] [Related]
18. Penicillamine hepatotoxicity in the treatment of Wilson's disease. Menara M, Zancan L, Sturniolo GC. J Pediatr Gastroenterol Nutr; 1992 Apr 03; 14(3):353-4. PubMed ID: 1619543 [No Abstract] [Full Text] [Related]
19. [A case of Wilson's disease recovering from severe brain damage--special reference to trientine and D-penicillamine therapy]. Ishitsu T, Chikazawa S. No To Hattatsu; 1989 May 03; 21(3):294-6. PubMed ID: 2736129 [No Abstract] [Full Text] [Related]